| Name |
aggrecan |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
| Structure |
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
None
|
| Diseases |
|
None
|
| GWAS |
|
- Alzheimer's disease (late onset) ( 30820047
)
- Alzheimer's disease or family history of Alzheimer's disease ( 33589840
)
- Cerebrospinal fluid neurofilament light levels ( 31930058
)
- Health literacy ( 31250787
)
- Metabolite levels ( 23823483
)
|
| Novel Interactors |
5 novel interactors:
BLM
IDH2
MAN2A2
SLCO3A1
STARD5
|
4 novel interactors:
ADRA2B
FAM32A
JAML
TPSAB1
|
| Interacting Genes |
18 interacting genes:
ADAMTS1
ADAMTS4
ADAMTS5
CTSB
FBLN1
FBLN2
HAPLN1
LUM
MMP1
MMP14
MMP19
MMP2
MMP20
MMP3
MMP8
PTPRF
TNFAIP6
TNR
|
9 interacting genes:
A2M
ACAN
CFTR
DYRK1A
FURIN
KRT40
KRTAP10-8
VCAN
VEGFA
|
| Entrez ID |
176 |
9510 |
| HPRD ID |
01123
|
05530
|
| Ensembl ID |
ENSG00000157766
|
ENSG00000154734
|
| Uniprot IDs |
A0A5K1VW97
P16112
|
B2RB33
Q9UHI8
|
| PDB IDs |
4MD4
7RDV
|
2JIH
2V4B
3Q2G
3Q2H
|
| GO Terms Enriched among Interactors |
|
|